Kohler Health and Throne Roll Out AI Toilet Scanners for Gut Tracking Prompting Medical Skepticism and Privacy Concerns

Each unit houses an integrated optical camera directed downward into the toilet bowl. Both Kohler Health and Throne emphasize that physical design constraints prevent these cameras from tilting upward or capturing images outside the bowl environment. When a user sits down, built-in light sensors automatically trigger high-definition video recording of the user's deposits. That visual data is immediately processed by machine learning algorithms trained to assess various parameters, including stool consistency, color, urine clarity, and volume metrics. Within a few minutes of completing a bathroom visit, users receive a detailed digital report card on their mobile devices generated by an AI-powered application that calculates continuous hydration levels and digestive scores.

Developers of these devices stress that automated stool trackers represent a fundamental shift from traditional at-home gut microbiome testing kits. Microbiome testing kits typically require users to mail physical stool samples to laboratories with claims of uncovering food sensitivities and creating custom nutritional plans. However, clinical researchers have long criticized those mail-in kits for operating with minimal to non-existent scientific evidence regarding their efficacy. Instead of delivering binary determinations of whether a person's gut is healthy or unhealthy, AI toilet scanners focus on establishing a personal baseline of normal digestive activity for each individual user over extended periods.

Clinical Skepticism and Medical Utility Arguments

Despite the technologically sophisticated hardware, gastroenterology professionals question whether daily AI surveillance of stool is necessary or beneficial for the general public. Daniel Freedberg, a practicing gastroenterologist based in New York and an official spokesperson for the American Gastroenterological Association, suggests that automated stool scanning provides limited benefit for healthy individuals maintaining regular bowel movements. According to Freedberg, tracking bowel habits with camera-equipped toilets is largely unnecessary when individuals can simply observe their own stool directly. He notes that artificial intelligence has not yet demonstrated breakthrough scientific capabilities in routine digestive evaluation.

In response to skepticism from the medical community, Nora Tophof, managing director at Kohler Health, argues that digestive patterns vary significantly between individuals. She maintains that the core value of automated tracking lies in long-term data collection, allowing individuals to pinpoint specific triggers that affect their well-being. For example, users might discover through continuous logging that they consistently experience dehydration on weekends, or that particular ingredients and prescription medications consistently trigger gastrointestinal distress. Tophof notes that this granular, long-term perspective enables proactive lifestyle adjustments that might otherwise be overlooked.

From a clinical perspective, Scott Hickle, co-founder and chief executive officer of Throne, emphasizes that automated monitoring offers significant utility for patients managing chronic gastrointestinal conditions. Individuals diagnosed with inflammatory bowel disease or chronic digestive disorders are frequently instructed by their physicians to keep meticulous daily stool journals. However, patient compliance with manual logging is notoriously poor because individuals disfavor writing detailed notes about their bowel movements. Hickle explains that replacing manual record-keeping with automated computer vision removes friction for patients, providing gastroenterologists with reliable, continuous objective data.

Cancer Screening Ambitions and Fecal Blood Detection

Beyond daily gut wellness, hardware developers are attempting to leverage stool monitoring to address critical public health challenges, including the rising incidence of colorectal cancer. Over the past decade, colorectal cancer rates among younger adults have surged, making it the leading cause of cancer death among individuals under 50 years of age. Medical researchers suspect that increased environmental exposure to microplastics, widespread consumption of ultra-processed foods, and frequent antibiotic use may contribute to this demographic shift, though definitive causes remain under investigation. Traditional screening for colon cancer relies primarily on invasive colonoscopies or specialized laboratory tests designed to detect microscopic traces of blood in fecal samples.

Throne aims to incorporate advanced diagnostic capabilities into future iterations of its hardware. Scott Hickle reveals that the company is developing a next-generation device utilizing multispectral imaging technology capable of detecting occult blood in fecal matter with far greater sensitivity than the human eye. Early testing with prototype models has yielded promising results, and Throne plans to introduce the updated device within two years. Although pricing for the next-generation model has not been established, Hickle states the company intends to make the technology as accessible as possible to maximize public health benefits. While it remains unverified whether multispectral imaging can rival certified medical laboratory diagnostics, Hickle notes that identifying recurring bleeding patterns over weeks or months provides crucial evidence for users to consult medical professionals promptly. He clarifies that Throne does not intend to act as a diagnostic authority, but rather as an early warning mechanism.

Similarly, Kohler Health reports that its existing stool tracking system is already programmed to send automated alerts when it detects signs of blood in the toilet bowl. While fecal blood can frequently stem from benign issues such as hemorrhoids or menstrual cycles, it can also serve as an early indicator of severe gastrointestinal pathologies. Nora Tophof stresses that the company's ultimate objective is to assist individuals in recognizing early warning signs and potentially saving lives through timely medical intervention.

However, medical experts urge caution regarding the use of commercial smart toilets as broad cancer screening instruments. Gianluca Ianiro, an assistant professor of gastroenterology at the Catholic University of Rome, emphasizes that population-wide screening tools must satisfy strict clinical criteria, requiring non-invasive procedures to be highly cost-effective. Given that current smart toilets carry high upfront purchase costs alongside recurring subscription fees, Ianiro argues that these devices are currently far too expensive to serve as viable mass screening tools for cancer or other major health risks.

Data Privacy Risks, Location Tracking, and Subscription Model Concerns

The introduction of internet-connected cameras into residential bathrooms has raised severe privacy concerns among digital rights advocates. Lauren Hendry Parsons, a digital rights advocate at the Mozilla Foundation, warns consumers to carefully evaluate the trade-offs of surrendering sensitive personal health data to private corporations. She notes that consumers who pay continuous subscription fees to access their own biological data risk becoming trapped in long-term lock-in dynamics. As users accumulate years of personal health history within a proprietary ecosystem, disengaging from the service becomes increasingly difficult, forcing continued subscription payments.

The scope of data collected by smart toilet applications extends beyond visual stool analysis. In addition to images of toilet contents and user-entered details regarding diet, symptoms, and medication, both Kohler Health and Throne harvest standard personal identification data, including names, email addresses, and demographic details. Notably, Kohler Health's privacy policy indicates that it tracks users' precise geographic location, whereas Throne does not collect precise location data. Both companies state in their privacy documentation that they do not share personal health information with third parties for targeted advertising purposes.

However, privacy policies for both Kohler Health and Throne specify several exceptions where user data may be disclosed to external parties. Personal data can be shared with law enforcement agencies upon legal demand, transferred to corporate entities in the event of a merger, acquisition, or asset sale, and disclosed to third-party vendor service providers handling information technology infrastructure, customer service operations, and user engagement analytics. Nora Tophof states that Kohler Health has no plans to sell consumer health data, while Scott Hickle asserts that Throne will never monetize user health data without explicit consent. Hickle adds that Throne intends to allow users to opt into sharing anonymized data with university researchers studying gut health, emphasizing that declining to participate in research will not restrict access to device features.

Digital rights advocates stress that consumers must weigh the tangible medical benefits against privacy exposure when considering bathroom smart technology. Lauren Hendry Parsons advises potential buyers to thoroughly review data handling terms and consider whether their personal health circumstances justify the exposure. For patients suffering from severe conditions like Crohn's disease, automated monitoring may offer life-improving management tools. Conversely, for casual health enthusiasts simply curious about their digestive response to specialty foods like kombucha, the privacy trade-offs and recurring financial obligations may far outweigh the practical benefits.